tesaglitazar targets PPARα
Evidence from:
primary |
all sources
Evidence (2 sources)
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
tesaglitazar which binds and activates PPARα and PPARγ
confidence: 0.98
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
tesaglitazar should increase fatty acid oxidation capacity via PPARα activation suggested by previous studies...
confidence: 0.85